Dellora Investments LP

13D and 13G Filings

13D/G filings
13G on 6 securities
CIK
0001943462
All SEC filings
View on sec.gov
Issuer % of Class Filed
Whitehawk Therapeutics, Inc. 13G
WHWK · 00032Q104
5.6% 11/16/2026
Event 9/30/2026
Verrica Pharmaceuticals Inc. 13G
VRCA · 92511W207
5.2% 11/16/2026
Event 9/30/2026
Tenax Therapeutics, Inc. 13G/A Amendment 5
TENX · 88032L605
6.4% 10/9/2026
Event 10/2/2026
Rezolute, Inc. 13G
RZLT · 76200L309
5.9% 8/12/2026
Event 8/5/2026
Tenax Therapeutics, Inc. 13G/A Amendment 4
TENX · 88032L605
2.3% 5/15/2026
Event 3/31/2026
Tenax Therapeutics, Inc. 13G/A Amendment 3
TENX · 88032L605
6.4% 2/17/2026
Event 12/31/2025
Tenax Therapeutics, Inc. 13G/A Amendment 2
TENX · 88032L605
8.8% 4/4/2025
Event 3/5/2025
Tenax Therapeutics, Inc. 13G/A Amendment 1
TENX · 88032L605
10.3% 1/15/2025
Event 1/8/2025
Palvella Therapeutics, Inc. 13G/A Amendment 2
PVLA · 697947109
1.3% 12/17/2024
Event 12/13/2024
Pieris Pharmaceuticals, Inc. 13G/A Amendment 1
PIRS · 720795202
10.7% 12/6/2024
Event 11/6/2024
Tenax Therapeutics, Inc. 13G
TENX · 88032L605
6.9% 12/5/2024
Event 11/27/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.